Randomized Controlled Trial
Copyright ©The Author(s) 2024.
World J Diabetes. Aug 15, 2024; 15(8): 1734-1741
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1734
Table 1 Comparison of baseline clinical data, n (%)
Clinical parameters
Multi-point mode, n = 26
Single point mode, n = 23
t/χ²
P value
Male sex16 (61.64)12 (52.17)0.4370.509
Average age in years44.92 ± 6.3544.22 ± 6.400.3840.703
Average body mass index in kg/m222.80 ± 2.8723.95 ± 2.501.4860.144
Smoking3 (11.54)4 (17.39)0.3410.559
Alcohol drinker3 (11.54)3 (13.04)0.0260.873
ALT in U/L29.11 ± 14.5429.83 ± 14.130.1750.862
AST in U/L34.22 ± 16.6436.20 ± 17.020.4110.683
FBG in mmol/L5.20 ± 0.855.30 ± 1.010.3760.708
Creatinine in μmol/L72.48 ± 14.7363.26 ± 17.671.9920.052
Creatine kinase in U/L181.87 ± 135.88177.37 ± 114.540.1240.902
Uric acid in μmol/L373.43 ± 95.80389.90 ± 96.510.5990.552
Concurrent diseases                        
Hypertension2 (7.69)4 (17.39)1.0680.301
Nonalcoholic fatty liver disease2 (7.69)1 (4.35)0.2380.626
Liver cirrhosis1 (3.85)0 (0.00)0.9030.342